United States Oncology Regulatory Affairs Corporate Office

Clinical research site in Nashville, Tennessee

As of September 2026, 4 paid clinical trials are recruiting at United States Oncology Regulatory Affairs Corporate Office in Nashville, Tennessee. Active studies at this site cover conditions such as Metastatic Castration-resistant Prostate Cancer, Small-cell Lung Cancer and Extensive Stage Small-cell Lung Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

New trial at United States Oncology Regulatory Affairs Corporate Office? We'll email you when one opens.

Recruiting clinical trials at United States Oncology Regulatory Affairs Corporate Office (4)

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

for Metastatic Castration-resistant Prostate Cancer

43 locations incl. Goodyear

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07213674·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

for Small-cell Lung Cancer

50 locations incl. Casa Grande

Sponsor: Amgen

Sex: All·Age: 18 - 99

Code: NCT07005128·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

for Prostate Cancer

21 locations incl. Duarte

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT04221542·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

for Non-Small Cell Lung Cancer (NSCLC)

21 locations incl. Santa Barbara

Sponsor: Amgen

Sex: All·Age: 18 - 100

Code: NCT05920356·Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

Get new-trial alerts for United States Oncology Regulatory Affairs Corporate Office

We'll email you whenever a new clinical trial starts recruiting at this research site in Nashville, TN. Unsubscribe anytime.

More research sites in Nashville

Vanderbilt University Medical Center (371 trials)
SCRI Oncology Partners (129 trials)
Vanderbilt University/Ingram Cancer Center (83 trials)
Sarah Cannon Research Institute (62 trials)
Vanderbilt University (55 trials)
Tennessee Oncology (49 trials)
Vanderbilt-Ingram Cancer Center (36 trials)
The Children's Hospital at TriStar Centennial (27 trials)
Vanderbilt Breast Center at One Hundred Oaks (14 trials)
Monroe Carell Jr. Children's Hospital at Vanderbilt (13 trials)

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Nashville, TN · Tennessee clinical trials